← Return to Going Beyond Standard Immunotherapy
DiscussionGoing Beyond Standard Immunotherapy
Lung Cancer | Last Active: Sep 14, 2021 | Replies (42)Comment receiving replies
Replies to "I’m not sure this is the right place to post this but have to start somewhere...."
@dutchw- Good morning and Welcome to Mayo Clinic Connect. Thank you for sharing your story. I am a mentor for Mayo Connect's Lung Cancer and Lung Diseases. I have an unusual lung cancer called Multifocal Adenocarcinoma. I have survived two types of lung cancer for 23+ years and have never had immunotherapy, although I have had chemotherapy. I am sorry if I have given the impression that I have taken this wonderful drug.
@miriam57; @richcolleen- I have found that many people who have finished their two years on Keytruda are followed very closely with CT scans. I am at a loss to tell you that there are other drugs right now that will maintain you. Keytruda is "Humanized antibodies" This means that they are antibodies from non-human species whose protein sequences have been modified to increase their similarity to antibody variants produced naturally in humans. I certainly hope that the positive outcomes for many people who have taken this drug will see many more and maybe even a possibility for a maintenance program. I just don't know of any at this time.
The developers for Keytruda limited the study to two years. There was a lot of competition between several drug makers for the success of such a drug. You can read more of this here:
https://en.wikipedia.org/wiki/Pembrolizumab
The reason that I am suggesting that you read Wikipedia about your drug is so that you can see why there was a 2-year limit.
I am very glad that this drug's targeted population has expanded into many cancers.
https://www.keytruda.com/
Hola, fue la inmunoterapia la que le ayudo?
Thank you for sharing this information. Keytruda has been brought to me as an option. My question, if two years is the limit, what happens after that?